INS and obesity disorder: Further studies are necessary to investigate the impact of Sfrp5 on insulin secretion in isolated islets and/or primary beta cells from rats and humans and to evaluate whether Sfrp5 might be of therapeutic interest for the treatment of obesity and diabetes.